Companies / Creative Biolabs / Anti-CD229 (2D3) h(scFv-CD3_) TRuC-Jurkat Cells
Creative Biolabs

Anti-CD229 (2D3) h(scFv-CD3_) TRuC-Jurkat Cells | Creative Biolabs

The T cell receptor fusion construct (TRuC) comprising an antibody-based binding domain fused to T cell receptor (TCR) subunit can effectively reprogram an intact TCR complex to recognize tumor surface antigens. Unlike CAR, TRuC become a functional component of the TCR complex. TRuC-T cells kill tumor cells as potently as second-generation CAR-T cells, but at significant lower cytokine release and despite the absence of an extra co-stimulatory domain.

Supporting Documents


Data Sheet

Datasheet

Reviews


No reviews yet

ABOUT THE COMPANY

Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.